Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
fda
investing
2
×
life sciences
national blog main
national top stories
roche
2
×
san francisco blog main
san francisco top stories
acute myeloid leukemia
american society of clinical oncology
applied therapeutics
avapritinib
biosimilars
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
cancer
cell therapy
christopher heery
cincor pharma
cstone pharmaceuticals
cystic fibrosis
detroit blog main
detroit top stories
diabetic cardiomyopathy
drug prices
drugs
duchenne muscular dystrophy
elevatebio
eli lilly
eqt partners
european medicines agency
federal trade commission
What
fda
2
×
ahead
approval
asco
bio
blueprint
branded
cancer
candidate
choices
commissioner
consumers
costly
counterweight
currently
drug
drugs
elevatebio
generic
graft
marketing
medications
medicines
muscle
pact
regulatory
ret
review
rises
roche
roundup
supposed
team
tenure
wins
Language
unset
Current search:
investing
×
roche
×
fda
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More